188 related articles for article (PubMed ID: 26979287)
21. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production.
Angulo I; Jiménez-Díaz MB; García-Bustos JF; Gargallo D; de las Heras FG; Muñoz-Fernández MA; Fresno M
Cell Immunol; 2002; 218(1-2):46-58. PubMed ID: 12470613
[TBL] [Abstract][Full Text] [Related]
22. Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors.
Rosu-Myles M; Taylor BJ; Wolff L
Exp Hematol; 2007 Mar; 35(3):394-406. PubMed ID: 17309820
[TBL] [Abstract][Full Text] [Related]
23. Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.
Adamiak M; Abdelbaset-Ismail A; Moore JB; Zhao J; Abdel-Latif A; Wysoczynski M; Ratajczak MZ
Stem Cell Rev Rep; 2017 Feb; 13(1):92-103. PubMed ID: 27752990
[TBL] [Abstract][Full Text] [Related]
24. Lead Transiently Promotes Granulocyte-Macrophage Progenitor Differentiation and Subsequently Suppresses Common Myeloid Progenitor Differentiation.
Li Q; Zhang P; Yu X; Zhao Y; Li Q; Zhang Y; Yang Z; Xie Y; Xue P; Sun S; Jia X; Zhou Z; He M; Zhang Y
Toxicol Sci; 2017 Dec; 160(2):268-283. PubMed ID: 28973681
[TBL] [Abstract][Full Text] [Related]
25. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes.
Yáñez A; Coetzee SG; Olsson A; Muench DE; Berman BP; Hazelett DJ; Salomonis N; Grimes HL; Goodridge HS
Immunity; 2017 Nov; 47(5):890-902.e4. PubMed ID: 29166589
[TBL] [Abstract][Full Text] [Related]
27. Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression.
Bunting KD; Yu WM; Bradley HL; Haviernikova E; Kelly-Welch AE; Keegan AD; Qu CK
J Leukoc Biol; 2004 Aug; 76(2):484-90. PubMed ID: 15123777
[TBL] [Abstract][Full Text] [Related]
28. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.
Nutt SL; Metcalf D; D'Amico A; Polli M; Wu L
J Exp Med; 2005 Jan; 201(2):221-31. PubMed ID: 15657291
[TBL] [Abstract][Full Text] [Related]
29. Flk2+ myeloid progenitors are the main source of Langerhans cells.
Mende I; Karsunky H; Weissman IL; Engleman EG; Merad M
Blood; 2006 Feb; 107(4):1383-90. PubMed ID: 16263793
[TBL] [Abstract][Full Text] [Related]
30. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
Wu WC; Sun HW; Chen HT; Liang J; Yu XJ; Wu C; Wang Z; Zheng L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4221-6. PubMed ID: 24591638
[TBL] [Abstract][Full Text] [Related]
31. Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in mice.
Alemdehy MF; van Boxtel NG; de Looper HW; van den Berge IJ; Sanders MA; Cupedo T; Touw IP; Erkeland SJ
Blood; 2012 May; 119(20):4723-30. PubMed ID: 22353998
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis.
DiVita Dean B; Wildes T; Dean J; Yegorov O; Yang C; Shin D; Francis C; Figg JW; Sebastian M; Font LF; Jin D; Reid A; Moore G; Fernandez B; Wummer B; Kuizon C; Mitchell D; Flores CT
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750252
[TBL] [Abstract][Full Text] [Related]
33. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
[TBL] [Abstract][Full Text] [Related]
34. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
35. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.
Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA
Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958
[TBL] [Abstract][Full Text] [Related]
36. Adult T-cell progenitors retain myeloid potential.
Wada H; Masuda K; Satoh R; Kakugawa K; Ikawa T; Katsura Y; Kawamoto H
Nature; 2008 Apr; 452(7188):768-72. PubMed ID: 18401412
[TBL] [Abstract][Full Text] [Related]
37. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
38. Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells.
Jassinskaja M; Pimková K; Arh N; Johansson E; Davoudi M; Pereira CF; Sitnicka E; Hansson J
Cell Rep; 2021 Mar; 34(12):108894. PubMed ID: 33761361
[TBL] [Abstract][Full Text] [Related]
39. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
[TBL] [Abstract][Full Text] [Related]
40. Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors.
Karsunky H; Merad M; Mende I; Manz MG; Engleman EG; Weissman IL
Exp Hematol; 2005 Feb; 33(2):173-81. PubMed ID: 15676211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]